After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

European equities traded in the US as American depositary receipts were treading water late Monday morning, edging 0.04% higher to 1,357.59 on the S&P Europe Select ADR Index. From continental Europe, ...

Judge José Luis Calama of the National Court, who is investigating the Grifols case, has asked the National Securities Market Commission ...

Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator ...

Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator to bolster their cases as they prepare to face off in court.

The global biologics contract development and manufacturing organization (cdmo) market size is estimated to grow by USD 16.32 ...

2025 U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency from the embattled pharmaceutical company ...

Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to find biomarkers for Parkinson's in plasma that could help to predict if an ...

The unique plasma assets serve as the foundation of the Chronos-PD program, driving advanced research at Grifols subsidiary Alkahest, which is leading the initiative given its specialization in the ...

Grifols’ repository of PD plasma ... and for manufacturing pharmaceutical and diagnostic products. The company also supplies tools, information and services that enable hospitals, pharmacies ...